AlzBiomarker
MCI-AD vs MCI-Stable: Aβ38 (CSF)
Meta-analysis Results: Baseline levels of Aβ38 in the cerebrospinal fluid were marginally elevated in people with mild cognitive impairment who went on to develop Alzheimer’s dementia versus those who did not progress at follow-up. The analysis is limited to two eligible comparisons (effect size = 1.127, p = 0.01000).

